Cargando…
Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL...
Autores principales: | Visweshwar, Nathan, Rico, Juan Felipe, Killeen, Robert, Manoharan, Arumugam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482611/ https://www.ncbi.nlm.nih.gov/pubmed/37692863 http://dx.doi.org/10.14740/jh1112 |
Ejemplares similares
-
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?
por: Visweshwar, Nathan, et al.
Publicado: (2022) -
Insights into the Impact of Hesitancy on Cancer Care and COVID-19
por: Visweshwar, Nathan, et al.
Publicado: (2023) -
Chryseobacterium gleum Causing Healthcare-Associated Pneumonia in an Adult Male With Diffuse Large B Cell Lymphoma
por: Amisha, FNU, et al.
Publicado: (2021) -
Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021) -
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
por: Wu, Jianbo, et al.
Publicado: (2023)